Latest catheter Stories
ST. LOUIS, Jan. 10, 2012 /PRNewswire/ -- Stereotaxis, Inc. (NASDAQ: STXS) today announced the completion of the first 50 clinical procedures using the Company's new Niobe ES(TM) system to treat patients with a variety of complex cardiac arrhythmias. A majority of the first 50 cases were performed to treat atrial fibrillation (AF), the most common type of cardiac arrhythmia(1). Positive initial results with the Niobe ES system in Europe demonstrate that the average time for...
TAMPA, Fla., Dec. 21, 2011 /PRNewswire-USNewswire/ -- St. Joseph's Hospital Interventional Neuroradiologist Matthew Berlet, M.D. and Interventional Radiologist Glenn Stambo, M.D. are among the first in the county to treat acute ischemic stroke patients using a new device that rapidly restores blood flow to the brain. The Trevo(TM) is a minimally invasive catheter system that uses Stentriever(TM) technology to remove the blood clots that cause stroke. St. Joseph's is the only...
PLEASANTON, Calif., Dec. 21, 2011 /PRNewswire/ -- TriReme Medical, Inc. ("TriReme"), a leading developer of innovative devices for the treatment of complex vascular disease, announced today that it has received 510(K) clearance from the U.S. Food and Drug Administration to market its Chocolate PTA balloon catheter ("Chocolate") for the treatment of occluded peripheral arteries. Chocolate was developed in collaboration with TriReme's subsidiary, Quattro Vascular Pte Ltd...
SAN CLEMENTE, Calif., Dec. 13, 2011 /PRNewswire/ -- ICU Medical, Inc. (NASDAQ: ICUI) announced that a clinical study presented at the American Society of Nephrology's (ASN) Kidney Week 2011 showed the Tego(®) needlefree hemodialysis connector can decrease heparin use and reduce costs for dialysis clinics. As the world's first and only needlefree connector FDA-cleared for use in hemodialysis applications, the Tego connector provides a cost effective alternative to...
ST. LOUIS, Dec. 13, 2011 /PRNewswire/ -- Stereotaxis, Inc. (NASDAQ: STXS) today announced that the Company has started initial shipments of the Epoch platform, its comprehensive solution for the electrophysiology (EP) lab that is designed to increase efficiency in procedures with a fully-remote, networked robotic and magnetic navigation system. Initial shipments include system upgrades to the new generation Epoch platform from the Niobe® II navigation system for customers in...
University of Michigan Health System and Veterans Affairs Ann Arbor Healthcare Center study shows no-payment rule may not be enough to keep patients safe Hospitals are working harder than ever to prevent hospital-acquired infections, but a nationwide survey shows few are aggressively combating the most common one – catheter-associated urinary tract infections. In the survey by the University of Michigan Health System and the Veterans Affairs Ann Arbor Healthcare Center, as many as 90...
Study covered more than 6,000 men with urological emergency Men who experience a sudden inability to pass urine because of a non-cancerous enlarged prostate are hospitalised and treated differently depending on where they live, according to an international study published online by the urology journal BJUI. The paper, which will appear in the January issue, reports on how nearly 1,000 clinicians in 15 countries responded to this urological emergency in more than 6,000 men. "Acute...
NATICK, Mass., Nov. 22, 2011 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) announces U.S. Food and Drug Administration (FDA) approval for the PROMUS Element(TM) Plus Everolimus-Eluting Platinum Chromium Coronary Stent System, the Company's next-generation drug-eluting stent (DES) technology. The PROMUS Element Stent, designed to provide physicians improved DES performance in treating patients with coronary artery disease, is built on an innovative platinum chromium...
NEW YORK, Nov. 16, 2011 /PRNewswire/ -- Hotspur Technologies today announced the launch of the company's GPSCath(TM) Balloon Dilatation Catheter in the United States and select international markets. The company made the announcement today. Hotspur's innovative GPSCath(TM) Balloon Dilatation Catheter integrates a proprietary valve into a balloon catheter, allowing physicians to inject contrast during a procedure without the need for removal of the balloon catheter or...
WARRENDALE, Pa., Nov. 10, 2011 /PRNewswire/ -- Bayer HealthCare's affiliate MEDRAD, Inc. today announced that five-year data from the THUNDER trial* demonstrated a 59 percent relative reduction in target lesion revascularization (TLR) rates in popliteal arteries of patients with peripheral arterial disease (PAD) treated with the Cotavance® drug eluting balloon with Paccocath® technology compared to standard balloon angioplasty (POBA). Additionally, for patients requiring TLR, the...
Latest catheter Reference Libraries
Intravenous therapy, commonly known as IV therapy, is known as the administration of a liquid substance directly into a vein. It is also known as drip therapy, because most often the liquid is suspended above the IV site by an infusion pump, and runs through a drip chamber, which prevents air from entering the line. IVs are the preferred method of drug administration in hospital settings because they are the fastest known route of getting medication to the body. Intravenous therapy can also...
Interventional radiology (IR) is a special sub-operation under general radiology. It is used to find, diagnose and treat a disease in almost every body system. The process of interventional radiology is very noninvasive to help with the recovery and outcome of the procedure. It utilizes x-rays, CT, ultrasound, MRI, and other modes of imaging in order to direct tools in the body as well as a variety of catheters, narrow tubes, so that incisions can be minimalized. How it is Performed...
